Literature DB >> 23500680

Regulation of angiogenesis by PI3K signaling networks.

Mariona Graupera1, Michael Potente.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) are an evolutionary conserved family of lipid kinases that control cell growth, metabolism and survival. By generating lipid second messengers that interact with specialized lipid-binding domains found in a wide spectrum of signaling molecules, PI3Ks instigate signaling through a network of downstream effector pathways. Genetic studies in zebrafish and mice revealed the critical importance of intact PI3K signaling in the endothelium and provided first insights into how individual PI3K isoforms are utilized to control vascular development and function. Here, we review the myriad roles of PI3Ks in the endothelium and the mechanisms through which they couple environmental signals with specific steps of angiogenic vessel growth.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500680     DOI: 10.1016/j.yexcr.2013.02.021

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  40 in total

Review 1.  Molecules in medicine mini-review: isoforms of PI3K in biology and disease.

Authors:  Bart Vanhaesebroeck; Maria A Whitehead; Roberto Piñeiro
Journal:  J Mol Med (Berl)       Date:  2015-12-10       Impact factor: 4.599

2.  Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells.

Authors:  Peter V Usatyuk; Panfeng Fu; Vijay Mohan; Yulia Epshtein; Jeffrey R Jacobson; Julian Gomez-Cambronero; Kishore K Wary; Vytas Bindokas; Steven M Dudek; Ravi Salgia; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

3.  Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.

Authors:  Matthias Kolibabka; Nadine Dietrich; Thomas Klein; Hans-Peter Hammes
Journal:  Diabetologia       Date:  2018-08-10       Impact factor: 10.122

Review 4.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

Review 5.  Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.

Authors:  Adviye Ergul; Mohammed Abdelsaid; Abdelrahman Y Fouda; Susan C Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

6.  Somatic PIK3CA mutations as a driver of sporadic venous malformations.

Authors:  Pau Castel; F Javier Carmona; Joaquim Grego-Bessa; Michael F Berger; Agnès Viale; Kathryn V Anderson; Silvia Bague; Maurizio Scaltriti; Cristina R Antonescu; Eulàlia Baselga; José Baselga
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

7.  Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.

Authors:  Kyu-Yeon Han; Jin-Hong Chang; Jennifer Dugas-Ford; Jonathan S Alexander; Dimitri T Azar
Journal:  FEBS Lett       Date:  2014-10-02       Impact factor: 4.124

Review 8.  Cerebral insulin, insulin signaling pathway, and brain angiogenesis.

Authors:  Yi Zeng; Le Zhang; Zhiping Hu
Journal:  Neurol Sci       Date:  2015-10-06       Impact factor: 3.307

9.  PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.

Authors:  Wenyi Wu; Guohong Zhou; Haote Han; Xionggao Huang; Heng Jiang; Shizuo Mukai; Andrius Kazlauskas; Jing Cui; Joanne Aiko Matsubara; Bart Vanhaesebroeck; Xiaobo Xia; Jiantao Wang; Hetian Lei
Journal:  Diabetes       Date:  2020-01-08       Impact factor: 9.461

10.  Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.

Authors:  Sandra D Castillo; Elena Tzouanacou; May Zaw-Thin; Inma M Berenjeno; Victoria E R Parker; Iñigo Chivite; Maria Milà-Guasch; Wayne Pearce; Isabelle Solomon; Ana Angulo-Urarte; Ana M Figueiredo; Robert E Dewhurst; Rachel G Knox; Graeme R Clark; Cheryl L Scudamore; Adam Badar; Tammy L Kalber; Julie Foster; Daniel J Stuckey; Anna L David; Wayne A Phillips; Mark F Lythgoe; Valerie Wilson; Robert K Semple; Neil J Sebire; Veronica A Kinsler; Mariona Graupera; Bart Vanhaesebroeck
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.